|“|| Evidence-based medicine is driven by the effort to minimize medical risk. In the area of ME/CFS, however, it has long been routine for psychosomatic research to proceed as if medical risk can be ignored, as if it simply is not possible that patients with this poorly understood condition are suffering from a biomedical disease.
That oversight can no longer be maintained in credible debate and research.
—Diane O'Leary, Journal of Medical Ethics blog 2019
Notable studies[edit | edit source]
- 2019, Bodily Distress Syndrome: Concerns About Scientific Credibility in Research and Implementation(Full text)
- 2018, Why Bioethics Should Be Concerned With Medically Unexplained Symptoms(Full text)
Letters, talks and blogs[edit | edit source]
Online presence[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- "Diane O'Leary » The Kennedy Institute of Ethics". The Kennedy Institute of Ethics. Retrieved Mar 5, 2019.
- O'Leary, Diane (Mar 5, 2019). "It's Time to Pay Attention to "Chronic Fatigue Syndrome"". Journal of Medical Ethics. Retrieved Mar 5, 2019.
- O’Leary, D. (Jun 30, 2018). "Bodily distress syndrome: Concerns about scientific credibility in research and implementation". Journal of Biological Physics and Chemistry. 18 (2): 67–77t. doi:10.4024/07LE18A.jbpc.18.02.
- O'Leary, Diane (May 2018). "Why Bioethics Should Be Concerned With Medically Unexplained Symptoms" (PDF). The American journal of bioethics: AJOB. 18 (5): 6–15. doi:10.1080/15265161.2018.1445312. ISSN 1536-0075. PMID 29697324.